Gene Delivery Technologies Market by Type, Application, End User, Disease Indication - Global Forecast 2025-2030- Product Image

Sale

Gene Delivery Technologies Market by Type, Application, End User, Disease Indication - Global Forecast 2025-2030

Report
181 Pages
October 2024
Region: Global
360iResearch™
ID: 6017034

UP TO €668EUR$697USD£557GBP OFF until Dec 31^st 2024

The Gene Delivery Technologies Market grew from USD 4.34 billion in 2023 to USD 4.94 billion in 2024. It is expected to continue growing at a CAGR of 14.82%, reaching USD 11.43 billion by 2030.

Gene delivery technologies refer to methods and systems designed for the delivery of therapeutic genes into patient cells to correct genetic disorders or enhance biological functions. The field is crucial for the advancement of gene therapy, precision medicine, and biotechnology applications. It's primarily employed in the treatment of genetic disorders, infectious diseases, and cancers, with applications extending to vaccine development and regenerative medicine. End-use sectors include pharmaceutical companies, academic research institutions, and clinical laboratories, highlighting its vast application scope. Market growth is driven by factors like increased gene therapy R&D, a rising prevalence of genetic disorders, and regulatory support for gene-based treatments. Recent advancements in delivery vectors, such as viral and non-viral systems, present potential opportunities, particularly with CRISPR technology, providing pathways for more effective and precise genome editing.

However, market growth is constrained by challenges like high development costs, potential immunogenic responses, and ethical concerns regarding genetic modifications. Furthermore, the complexity of achieving targeted delivery and ensuring long-term expression of the therapeutic gene adds to the hurdles. Innovation is necessary in developing more efficient, safe, and cost-effective delivery systems. Opportunities for growth lie in harnessing novel technologies like lipid nanoparticles and synthetic vectors, which show promise in overcoming current limitations. Engagement in collaborative research partnerships and investments in next-generation sequencing can also enhance market potential. The market is highly dynamic, characterized by rapid technological advancements and a competitive landscape. Companies focusing on strategic partnerships and continuous innovation are likely to thrive. In summary, while gene delivery technologies hold significant promise for transforming healthcare, addressing the existing challenges through innovation and collaboration is essential to fully realize its market potential.

Understanding Market Dynamics in the Gene Delivery Technologies Market

The Gene Delivery Technologies Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Expansion of applications in agriculture and veterinary sciences
- Collaboration between academic institutions and biopharmaceutical companies for innovative solutions
- Government initiatives and regulatory support for gene therapy advancements
- Emergence of novel viral and non-viral vectors for efficient gene delivery
Market Restraints
- Technical challenges in achieving efficient and targeted delivery of therapeutic genes
- Limited availability of skilled professionals and expertise in gene delivery technologies
Market Opportunities
- Innovative gene delivery methods for rare genetic disorder treatments showing significant advancements
- High potential in developing non-viral vectors for safer gene therapies limiting immune responses
- Expanding gene therapy applications for age-related conditions such as macular degeneration and arthritis
Market Challenges
- High development costs and R&D investments impacting gene delivery technologies market
- Intellectual property and patent challenges in the gene delivery space affecting market dynamics

Exploring Porter’s Five Forces for the Gene Delivery Technologies Market

Porter’s Five Forces framework further strengthens the insights of the Gene Delivery Technologies Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Gene Delivery Technologies Market

External macro-environmental factors deeply influence the performance of the Gene Delivery Technologies Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Gene Delivery Technologies Market

The Gene Delivery Technologies Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Gene Delivery Technologies Market

The Gene Delivery Technologies Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Gene Delivery Technologies Market

The Gene Delivery Technologies Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Delivery Technologies Market, highlighting leading vendors and their innovative profiles. These include Amgen, Avalanche Biotechnologies, Beam Therapeutics, BioNTech, Bluebird Bio, CRISPR Therapeutics, Editas Medicine, GlaxoSmithKline, Intellia Therapeutics, Moderna Therapeutics, Novartis, Pfizer, REGENXBIO, Roche, Sangamo Therapeutics, Sanofi, Spark Therapeutics, uniQure, Voyager Therapeutics, and Ziopharm Oncology.

Market Segmentation & Coverage

This research report categorizes the Gene Delivery Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Non-Viral Vector
  - Chemical Methods
    - Liposomes
    - Polymer Based
  - Physical Methods
    - Electroporation
    - Microinjection
    - Particle Bombardment
- Viral Vector
  - Adeno-Associated Virus
  - Adenovirus
  - Lentivirus
  - Retrovirus
Application
- Cell Therapy
- Gene Therapy
  - Monogenic Disorders
  - Multigenic Disorders
- Research
- Vaccines
  - Bacterial Vaccines
  - Viral Vaccines
End User
- Biotechnological Companies
- Contract Research Organizations
- Pharmaceutical Companies
- Research Institutes
Disease Indication
- Cancer
- Cardiovascular Diseases
- Genetic Disorders
  - Cystic Fibrosis
  - Muscular Dystrophy
- Infectious Diseases

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expansion of applications in agriculture and veterinary sciences
5.1.1.2. Collaboration between academic institutions and biopharmaceutical companies for innovative solutions
5.1.1.3. Government initiatives and regulatory support for gene therapy advancements
5.1.1.4. Emergence of novel viral and non-viral vectors for efficient gene delivery
5.1.2. Restraints
5.1.2.1. Technical challenges in achieving efficient and targeted delivery of therapeutic genes
5.1.2.2. Limited availability of skilled professionals and expertise in gene delivery technologies
5.1.3. Opportunities
5.1.3.1. Innovative gene delivery methods for rare genetic disorder treatments showing significant advancements
5.1.3.2. High potential in developing non-viral vectors for safer gene therapies limiting immune responses
5.1.3.3. Expanding gene therapy applications for age-related conditions such as macular degeneration and arthritis
5.1.4. Challenges
5.1.4.1. High development costs and R&D investments impacting gene delivery technologies market
5.1.4.2. Intellectual property and patent challenges in the gene delivery space affecting market dynamics
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Gene Delivery Technologies Market, by Type

6.1. Introduction
6.2. Non-Viral Vector
6.2.1. Chemical Methods
6.2.1.1. Liposomes
6.2.1.2. Polymer Based
6.2.2. Physical Methods
6.2.2.1. Electroporation
6.2.2.2. Microinjection
6.2.2.3. Particle Bombardment
6.3. Viral Vector
6.3.1. Adeno-Associated Virus
6.3.2. Adenovirus
6.3.3. Lentivirus
6.3.4. Retrovirus

7. Gene Delivery Technologies Market, by Application

7.1. Introduction
7.2. Cell Therapy
7.3. Gene Therapy
7.3.1. Monogenic Disorders
7.3.2. Multigenic Disorders
7.4. Research
7.5. Vaccines
7.5.1. Bacterial Vaccines
7.5.2. Viral Vaccines

8. Gene Delivery Technologies Market, by End User

8.1. Introduction
8.2. Biotechnological Companies
8.3. Contract Research Organizations
8.4. Pharmaceutical Companies
8.5. Research Institutes

9. Gene Delivery Technologies Market, by Disease Indication

9.1. Introduction
9.2. Cancer
9.3. Cardiovascular Diseases
9.4. Genetic Disorders
9.4.1. Cystic Fibrosis
9.4.2. Muscular Dystrophy
9.5. Infectious Diseases

10. Americas Gene Delivery Technologies Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Gene Delivery Technologies Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Gene Delivery Technologies Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. GENE DELIVERY TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 2. GENE DELIVERY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. GENE DELIVERY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. GENE DELIVERY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. GENE DELIVERY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GENE DELIVERY TECHNOLOGIES MARKET DYNAMICS
TABLE 7. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PARTICLE BOMBARDMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MONOGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MULTIGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY BACTERIAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MUSCULAR DYSTROPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 83. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 85. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 86. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 87. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 88. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 90. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 91. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 93. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 96. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 99. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 102. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 104. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 140. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 142. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 143. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 144. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 145. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 147. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 148. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 150. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 151. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 153. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 154. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 155. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 156. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 158. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 159. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 161. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 173. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 175. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 176. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 177. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 178. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 180. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 181. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 183. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 239. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 241. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 242. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 243. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 244. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 246. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 247. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 273. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 275. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 277. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 278. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 280. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 281. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 283. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 284. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 286. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 287. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 288. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 289. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 291. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 292. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 294. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 295. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 297. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 298. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 299. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 300. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 302. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 303. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 305. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 306. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 307. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 308. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 309. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 310. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 311. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 312. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
TABLE 313. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 314. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 316. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 317. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 318. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
TABLE 319. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
TABLE 320. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
TABLE 321. GERMANY GEN

Companies Mentioned

The leading players in the Gene Delivery Technologies Market, which are profiled in this report, include:

Amgen
Avalanche Biotechnologies
Beam Therapeutics
BioNTech
Bluebird Bio
CRISPR Therapeutics
Editas Medicine
GlaxoSmithKline
Intellia Therapeutics
Moderna Therapeutics
Novartis
Pfizer
REGENXBIO
Roche
Sangamo Therapeutics
Sanofi
Spark Therapeutics
uniQure
Voyager Therapeutics
Ziopharm Oncology

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.94 Billion
Forecasted Market Value ( USD ) by 2030	$ 11.43 Billion
Compound Annual Growth Rate	14.8%
Regions Covered	Global
No. of Companies Mentioned	20

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3397EUR$3,545USD£2,831GBP €3775EUR$3,939USD£3,145GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6011EUR$6,272USD£5,009GBP €6679EUR$6,969USD£5,565GBP

Understanding Market Dynamics in the Gene Delivery Technologies Market

Exploring Porter’s Five Forces for the Gene Delivery Technologies Market

Applying PESTLE Analysis to the Gene Delivery Technologies Market

Analyzing Market Share in the Gene Delivery Technologies Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Gene Delivery Technologies Market

Strategic Recommendations for Success in the Gene Delivery Technologies Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Drug & Gene Delivery Devices Market by Route of Administration, Method, Vector - Global Forecast 2025-2030

Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (AAV, Lentivirus, Retrovirus), By Application (Gene Therapy, Cell Therapy), By Method (Ex-vivo, In-vivo), By Region, And Segment Forecasts, 2024 - 2030

Gene Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

Gene Editing Market by Technology, Application, End User, Product & Service, Delivery Method - Global Forecast 2025-2030

Cell & Gene Therapy Drug Delivery Devices Market by Products, Commercialized Drugs - Global Forecast 2025-2030